News

Panel weighs in on the changing face of oncology


 

This shift in costs to patients is not a problem for most minor ailments, Mr. Okon said, but it is another matter entirely when it comes to cancer.
None of the panelists had any conflicts of interest to disclose.

Pages

Recommended Reading

MedPAC Ponders SGR Alternatives
MDedge Hematology and Oncology
Research Groups Ally as NCI Clinical Trials Program Begins Seismic Shift
MDedge Hematology and Oncology
Accountable Care Organizations Take Shape
MDedge Hematology and Oncology